½ÃÀ庸°í¼­
»óǰÄÚµå
1424009

¼¼°è Æä¼­¸® ½ÃÀå : Á¡À¯À², ±Ô¸ð, µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼­ - À¯Çüº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹® µ¿Çâ(2024³â-2032³â)

Pessary Market Share, Size, Trends, Industry Analysis Report, By Type (Gellhorn, Ring, Donut), By End-use (Hospitals, Ambulatory Surgical Centers, Clinics), By Region, And Segment Forecasts, 2024 - 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Polaris Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 117 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é Æä¼­¸® ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö 6¾ï 3,632¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇÐÀ» »ó¼¼ÇÏ°Ô ÀλçÀÌÆ®ÇÏ°í ¹Ì·¡ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

ÃÖ±Ù °ñ¹ÝÀå±â Å»¿¡ ´ëÇÑ ¼ö¼úº¸´Ù Æä¼­¸® ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ´Â °ÍÀº Æä¼­¸®¿Í °ü·ÃµÈ Æí¸®¼º°ú ÀåÂøÀÇ ¿ëÀ̼º¿¡ ±âÀÎÇϰí ÀÖ½À´Ï´Ù. ȯÀÚ´Â Á¾Á¾ ºñħ½ÀÀûÀÌ°í º¹ÀâÇÏÁö ¾ÊÀº ¼Ö·ç¼ÇÀ» ¼±È£Çϸç, Æä¼­¸®´Â ½Ç¿ëÀûÀÌ°í »ç¿ëÀÚ Ä£È­ÀûÀÎ ´ë¾ÈÀ» Á¦°øÇÕ´Ï´Ù. Æä¼­¸®´Â ½Ç¿ëÀûÀÌ°í »ç¿ëÇϱ⠽¬¿î ´ë¾ÈÀÔ´Ï´Ù. °£´ÜÇÑ Âø¿ë °úÁ¤°ú ¼ö¼ú ÀýÂ÷ÀÇ È¸Çǰ¡ °áÇÕµÇ¾î °ñ¹Ý Àå±â Å»ÀÇ °ü¸®¸¦ ¿ä±¸ÇÏ´Â »ç¶÷µé »çÀÌ¿¡¼­ Æä¼­¸®ÀÇ ÀαⰡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀÌ Ãß¼¼´Â °Ç°­ °ü¸®ÀÇ ³·Àº ħ½ÀÀ¸·Î ȯÀÚ Ä£È­Àû ÀÎ °³ÀÔ¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡¿Í ÀÏÄ¡ÇÕ´Ï´Ù.

¹Ì±¹ Àα¸Á¶»ç±¹¿¡¼­ ¾Ë ¼ö ÀÖµíÀÌ ¹Ì±¹Àº 2030³â±îÁö 65¼¼ ÀÌ»óÀÇ ¿©¼º ¼ö°¡ µÎ ¹è·Î ´Ã¾î³¯ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖÀ¸¸ç, ÀÌ °èÃþ¿¡ ÇØ´çÇÏ´Â °Ç°­ °ü¸® ¼Ö·ç¼ÇÀÇ Á߿伺ÀÌ ³ô¾ÆÁö°í ÀÖÀ½À» °­Á¶ÇÕ´Ï´Ù. Áú Æä¼­¸®´Â ÀÌ ³ëÀÎÃþ¿¡¼­ ½Ç±Ý°ú Å»Ç× ¸ðµÎ¸¦ ´Ù·ç´Â ³ôÀº ¼º°ø·ü°ú ÃÖ¼ÒÇÑÀÇ ÇÕº´Áõ·üÀ» °¡Áø ÁÖ¸ñÇÒ ¸¸ÇÑ ¼±ÅÃÀ¸·Î ¶°¿À¸£°í ÀÖ½À´Ï´Ù. ±× È¿´ÉÀº ÀûÀýÇÏ°Ô Âø¿ëÇßÀ» ¶§ ÇÕº´ÁõÀÇ À§ÇèÀÌ »ó´ëÀûÀ¸·Î ³·´Ù´Â °Í°ú ÇÔ²² ȯÀÚÀÇ ³ôÀº ¸¸Á·µµ¿¡ ±â¿©ÇÕ´Ï´Ù. ³ëÀÎ Àα¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó Áú Æä¼­¸®¿Í °°Àº È¿°úÀûÀÌ°í ³»¾àÇÑ Ä¡·á¹ý¿¡ ´ëÇÑ ¼ö¿ä°¡ °è¼Ó Ä¿Áú °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¾É¾ÆÀÖ´Â ¶óÀÌÇÁ ½ºÅ¸ÀÏ, »ýȰ ½À°üº´, ¿ä½Ç±Ý ¹× °ñ¹Ý Àå±â Å»¶ô°ú °°Àº Áúº´ÀÇ À¯º´·ü Áõ°¡¿ÍÀÇ ¿¬°ü¼ºÀº È¿°úÀûÀÎ °Ç°­ °ü¸® ¼Ö·ç¼ÇÀÇ Çʿ伺À» °­Á¶ÇÕ´Ï´Ù. °³ÀÎÀÌ ¾ÉÀ» ¼ö ÀÖ´Â ¶óÀÌÇÁ½ºÅ¸ÀÏÀ» ÃëÇÏ°Ô µÇ¸é °ñ¹ÝÀúÀå¾Ö¸¦ Æ÷ÇÔÇÑ Æ¯Á¤ °Ç°­ ¹®Á¦¿¡ °É¸®±â ½¬¿öÁú ¼ö ÀÖ½À´Ï´Ù. ³ëÀÎ Àα¸ Áõ°¡´Â Áú Æä¼­¸®¿Í °°Àº ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀÇ·á±â±â´Â ¿ä½Ç±Ý ¹× °ñ¹Ý Àå±â Å»¶ô°ú °°Àº Áõ»óÀ» °ü¸®Çϱâ À§ÇÑ ºñħ½ÀÀûÀ̰í ÁöÁöÀûÀÎ Á¢±Ù¹ýÀ» Á¦°øÇϸç, ³ëÀÎ Àα¸ÀÇ °Ç°­ °ü¸® ¿ä±¸¿¡ ºÎÇÕÇÕ´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ´Â °ÍÀº ÀÌ·¯ÇÑ Áõ»ó¿¡ ´ëÇÑ ÀǽÄÀÇ °íÁ¶¿Í, ½Ç¿ëÀûÀ̰í Àúħ½ÀÀûÀÎ °³ÀÔÀ» ¿ä±¸ÇÏ´Â »ç¶÷µéÀÇ ¿ä¸ÁÀÔ´Ï´Ù.

Áú Æä¼­¸® ½ÃÀåÀÇ °æÀïÀº µÎµå·¯Áö¸ç, CooperSurgical°ú °°Àº ±â¾÷µéÀÌ Milex Pessary Fitting KitÀÇ °³¹ß°ú °°Àº ¹ßÀüÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù. ÀÌ Å°Æ®´Â ÀÇ»ç¿Í Àǻ翡°Ô ±ÍÁßÇÑ µµ±¸À̸ç ȯÀÚ¿¡°Ô ÇÊ¿äÇÑ Á¤È®ÇÑ Å©±â¸¦ Æò°¡Çϰí ÀûÀýÇÑ Æä¼­¸®¸¦ ó¹æ ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ »ó¼¼ÇÑ ºÐ¼®ÀÇ ¼Ò°³´Â ¼¼°è ¿©¼º °Ç°­ °ü¸® ºÐ¾ß¿¡¼­ Áß¿äÇÑ ÁøÈ­¸¦ ÀǹÌÇÏ¸ç ½ÃÀåÀÇ Áøº¸ÀûÀÎ ±â¼¼¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

Æä¼­¸® ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¹ÝÁö Çü Æä¼­¸®´Â »ç¿ëÇϱ⠽±°í »ðÀÔÇϱ⠽±°í ½±°Ô Á¦°Å ÇÒ ¼ö Àֱ⠶§¹®¿¡ ½ÃÀåÀ» µ¶Á¡.

º´¿ø ºÎ¼­°¡ °¡Àå Å« ÆÇ¸Å Á¡À¯À²À» Â÷ÁöÇÕ´Ï´Ù.

¾öû³­ ¿©¼º Àα¸ÀÇ Á¸Àç, ÀÇ·á ÀÎÇÁ¶ó °³¼±, °¡Ã³ºÐ ¼Òµæ Áõ°¡·Î ¾Æ½Ã¾ÆÅÂÆò¾çÀº ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå ±â¾÷Àº Bioteque America, Bliss GVS Pharma, Cooper Surgical, Integra LifeSciences, MedGyn, Personal Medical, Wallach Surgical µîÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°è Æä¼­¸® ½ÃÀå ÀλçÀÌÆ®

  • Æä¼­¸® ½ÃÀå - ¾÷°è ½º³À¼¦
  • Æä¼­¸® ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀΰú ±âȸ
      • °ñ¹ÝÀúÁúȯÀÇ À¯º´·ü Áõ°¡
      • °è¹ß ¹× ±³À° ÇÁ·Î±×·¥
    • ¾ïÁ¦¿äÀΰú °úÁ¦
      • ÇÕº´ÁõÀÇ À§Çè
      • ¿Ü°úÀû °³ÀÔÀ» ¼±È£
  • PESTLE ºÐ¼®
  • Æä¼­¸® ¾÷°è µ¿Çâ
  • ¹ë·ùüÀÎ ºÐ¼®
  • COVID-19 °¨¿°ÀÇ ¿µÇ⠺м®

Á¦5Àå ¼¼°è Æä¼­¸® ½ÃÀå - À¯Çüº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
  • °ÖÈ£¸¥
  • ¸µ
  • µµ³Ó
  • ±âŸ

Á¦6Àå ¼¼°è Æä¼­¸® ½ÃÀå - ÃÖÁ¾ ¿ëµµº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
  • º´¿ø
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • Ŭ¸®´Ð

Á¦7Àå Áö¿ªº° ¼¼°è Æä¼­¸® ½ÃÀå

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
    • Æä¼­¸® ½ÃÀå Æò°¡, Áö¿ªº°(2019³â-2032³â)
  • Æä¼­¸® ½ÃÀå - ºÏ¹Ì
    • ºÏ¹Ì : Æä¼­¸® ½ÃÀå - ÃÖÁ¾ ¿ëµµº°(2019³â-2032³â)
    • ºÏ¹Ì : Æä¼­¸® ½ÃÀå - À¯Çüº°(2019³â-2032³â)
    • Æä¼­¸® ½ÃÀå - ¹Ì±¹
    • Æä¼­¸® ½ÃÀå - ij³ª´Ù
  • Æä¼­¸® ½ÃÀå - À¯·´
    • À¯·´: Æä¼­¸® ½ÃÀå - ÃÖÁ¾ ¿ëµµº°(2019³â-2032³â)
    • À¯·´: Æä¼­¸® ½ÃÀå - À¯Çüº°(2019³â-2032³â)
    • Æä¼­¸® ½ÃÀå - ¿µ±¹
    • Æä¼­¸® ½ÃÀå-ÇÁ¶û½º
    • Æä¼­¸® ½ÃÀå - µ¶ÀÏ
    • Æä¼­¸® ½ÃÀå - ÀÌÅ»¸®¾Æ
    • Æä¼­¸® ½ÃÀå - ½ºÆäÀÎ
    • Æä¼­¸® ½ÃÀå - ³×´ú¶õµå
    • Æä¼­¸® ½ÃÀå - ·¯½Ã¾Æ
  • Æä¼­¸® ½ÃÀå - ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾ç: Æä¼­¸® ½ÃÀå - ÃÖÁ¾ ¿ëµµº°(2019³â-2032³â)
    • ¾Æ½Ã¾ÆÅÂÆò¾ç: Æä¼­¸® ½ÃÀå - À¯Çüº°(2019³â-2032³â)
    • Æä¼­¸® ½ÃÀå- Áß±¹
    • Æä¼­¸® ½ÃÀå - Àεµ
    • Æä¼­¸® ½ÃÀå - ¸»·¹À̽þÆ
    • Æä¼­¸® ½ÃÀå - ÀϺ»
    • Æä¼­¸® ½ÃÀå - Àεµ³×½Ã¾Æ
    • Æä¼­¸® ½ÃÀå - Çѱ¹
  • Æä¼­¸® ½ÃÀå - Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«: Æä¼­¸® ½ÃÀå - ÃÖÁ¾ ¿ëµµº°(2019³â-2032³â)
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«: Æä¼­¸® ½ÃÀå - À¯Çüº°(2019³â-2032³â)
    • Æä¼­¸® ½ÃÀå - »ç¿ìµð¾Æ¶óºñ¾Æ
    • Æä¼­¸® ½ÃÀå - ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • Æä¼­¸® ½ÃÀå - À̽º¶ó¿¤
    • Æä¼­¸® ½ÃÀå - ³²¾ÆÇÁ¸®Ä«
  • Æä¼­¸® ½ÃÀå - ¶óƾ¾Æ¸Þ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä«: Æä¼­¸® ½ÃÀå - ÃÖÁ¾ ¿ëµµº°(2019³â-2032³â)
    • ¶óƾ¾Æ¸Þ¸®Ä«: Æä¼­¸® ½ÃÀå - À¯Çüº°(2019³â-2032³â)
    • Æä¼­¸® ½ÃÀå - ¸ß½ÃÄÚ
    • Æä¼­¸® ½ÃÀå - ºê¶óÁú
    • Æä¼­¸® ½ÃÀå - ¾Æ¸£ÇîÆ¼³ª

Á¦8Àå °æÀï ±¸µµ

  • È®Àå ¹× Àμö ºÐ¼®
    • È®´ë
    • Àμö
  • Á¦ÈÞ/Çù¾÷/ÇÕÀÇ/°ø°³

Á¦9Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • Bioteque America
  • Bliss GVS Pharma
  • CooperSurgical Inc
  • Dr. Arabin GmbH & Co. KG
  • Integra LifeSciences
  • MedGyn
  • Panpac Medical Corporation
  • Personal Medical Corporation
  • Wallach Surgical Devices
BJH 24.02.28

The global pessary market size is expected to reach USD 636.32 million by 2032, according to a new study by Polaris Market Research. The report "Pessary Market Share, Size, Trends, Industry Analysis Report, By Type (Gellhorn, Ring, Donut), By End-use (Hospitals, Ambulatory Surgical Centers, Clinics), By Region, And Segment Forecasts, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising demand for pessaries over surgeries for pelvic organ prolapse in recent years can be attributed to the convenience and ease of application associated with pessaries. Patients often prefer non-invasive and less complex solutions, and pessaries offer a practical and user-friendly alternative. The straightforward application process, coupled with the avoidance of surgical procedures, has contributed to the increasing popularity of pessaries among individuals seeking management for pelvic organ prolapse. This trend aligns with the growing preference for minimally invasive and patient-friendly interventions in healthcare.

The projected doubling of the number of women aged 65 years and above in America by 2030, as indicated by the U.S. Census Bureau, emphasizes the increasing significance of healthcare solutions catering to this demographic. Vaginal pessaries emerge as a notable option with a high success rate and minimal complication rate for addressing both incontinence and prolapse in this aging population. Their effectiveness, coupled with a relatively low risk of complications when properly fitted, contributes to high patient satisfaction. As the elderly population grows, the demand for effective and well-tolerated interventions like vaginal pessaries is expected to remain significant.

The association between sedentary lifestyles, lifestyle-related diseases, and the growing prevalence of conditions like urinary incontinence and pelvic organ prolapse underscores the need for effective healthcare solutions. As individuals adopt sedentary lifestyles, they may become more susceptible to certain health issues, including pelvic floor disorders. The rising number of geriatric individuals further amplifies the demand for solutions like vaginal pessaries. These medical devices offer a non-invasive and supportive approach to managing conditions such as urinary incontinence and pelvic organ prolapse, aligning with the healthcare needs of an aging population. The market growth is driven by the increasing awareness of these conditions and the desire for practical and minimally invasive interventions.

The competition in the vaginal pessary market is notable, with companies like CooperSurgical, making advancements such as the development of the Milex Pessary Fitting Kit. This kit serves as a valuable tool for physicians and doctors, enabling them to assess the precise size needed for a patient and prescribe the appropriate pessary. The introduction of such detailed analyses signifies a significant evolution in the realm of female healthcare on a global scale, contributing to the progressive momentum of the market.

Pessary Market Report Highlights

Ring pessary dominated the market, as they are easy to use, insert & can be easily removed

Hospitals segment held the largest revenue share, as they have better equipment and human resource to provide superior care to patients

Asia Pacific will grow rapidly, on account of presence of huge female population, improving medical infrastructure, and rise in disposable income

The key market players include Bioteque America, Bliss GVS Pharma, Cooper Surgical, Integra LifeSciences, MedGyn, Personal Medical, & Wallach Surgical.

Polaris Market Research has segmented the pessary market report based on type, end use, and region:

Pessary, Type Outlook (Revenue - USD Million, 2023 - 2032)

  • Gellhorn
  • Ring
  • Donut
  • Others

Pessary, End Use Outlook (Revenue - USD Million, 2023 - 2032)

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics

Pessary, Regional Outlook (Revenue - USD Million, 2023 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Pessary Market Insights

  • 4.1. Pessary Market - Industry Snapshot
  • 4.2. Pessary Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Prevalence of Pelvic Floor Disorders
      • 4.2.1.2. Awareness and Education Programs
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Risk of Complications
      • 4.2.2.2. Preference for Surgical Interventions
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Pessary Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Pessary Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Pessary, by Type, 2019-2032 (USD Million)
  • 5.3. Gellhorn
    • 5.3.1. Global Pessary Market, by Gellhorn, by Region, 2019-2032 (USD Million)
  • 5.4. Ring
    • 5.4.1. Global Pessary Market, by Ring, by Region, 2019-2032 (USD Million)
  • 5.5. Donut
    • 5.5.1. Global Pessary Market, by Donut, by Region, 2019-2032 (USD Million)
  • 5.6. Others
    • 5.6.1. Global Pessary Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Pessary Market, by End Use

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Pessary Market, by End Use, 2019-2032 (USD Million)
  • 6.3. Hospitals
    • 6.3.1. Global Pessary Market, by Hospitals, by Region, 2019-2032 (USD Million)
  • 6.4. Ambulatory Surgical Centers
    • 6.4.1. Global Pessary Market, by Ambulatory Surgical Centers, by Region, 2019-2032 (USD Million)
  • 6.5. Clinics
    • 6.5.1. Global Pessary Market, by Clinics, by Region, 2019-2032 (USD Million)

7. Global Pessary Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Pessary Market Assessment, By Geography, 2019-2032 (USD Million)
  • 7.3. Pessary Market - North America
    • 7.3.1. North America: Pessary Market, by End Use, 2019-2032 (USD Million)
    • 7.3.2. North America: Pessary Market, by Type, 2019-2032 (USD Million)
    • 7.3.3. Pessary Market - U.S.
      • 7.3.3.1. U.S.: Pessary Market, by End Use, 2019-2032 (USD Million)
      • 7.3.3.2. U.S.: Pessary Market, by Type, 2019-2032 (USD Million)
    • 7.3.4. Pessary Market - Canada
      • 7.3.4.1. Canada: Pessary Market, by End Use, 2019-2032 (USD Million)
      • 7.3.4.2. Canada: Pessary Market, by Type, 2019-2032 (USD Million)
  • 7.4. Pessary Market - Europe
    • 7.4.1. Europe: Pessary Market, by End Use, 2019-2032 (USD Million)
    • 7.4.2. Europe: Pessary Market, by Type, 2019-2032 (USD Million)
    • 7.4.3. Pessary Market - UK
      • 7.4.3.1. UK: Pessary Market, by End Use, 2019-2032 (USD Million)
      • 7.4.3.2. UK: Pessary Market, by Type, 2019-2032 (USD Million)
    • 7.4.4. Pessary Market - France
      • 7.4.4.1. France: Pessary Market, by End Use, 2019-2032 (USD Million)
      • 7.4.4.2. France: Pessary Market, by Type, 2019-2032 (USD Million)
    • 7.4.5. Pessary Market - Germany
      • 7.4.5.1. Germany: Pessary Market, by End Use, 2019-2032 (USD Million)
      • 7.4.5.2. Germany: Pessary Market, by Type, 2019-2032 (USD Million)
    • 7.4.6. Pessary Market - Italy
      • 7.4.6.1. Italy: Pessary Market, by End Use, 2019-2032 (USD Million)
      • 7.4.6.2. Italy: Pessary Market, by Type, 2019-2032 (USD Million)
    • 7.4.7. Pessary Market - Spain
      • 7.4.7.1. Spain: Pessary Market, by End Use, 2019-2032 (USD Million)
      • 7.4.7.2. Spain: Pessary Market, by Type, 2019-2032 (USD Million)
    • 7.4.8. Pessary Market - Netherlands
      • 7.4.8.1. Netherlands: Pessary Market, by End Use, 2019-2032 (USD Million)
      • 7.4.8.2. Netherlands: Pessary Market, by Type, 2019-2032 (USD Million)
    • 7.4.9. Pessary Market - Russia
      • 7.4.9.1. Russia: Pessary Market, by End Use, 2019-2032 (USD Million)
      • 7.4.9.2. Russia: Pessary Market, by Type, 2019-2032 (USD Million)
  • 7.5. Pessary Market - Asia Pacific
    • 7.5.1. Asia Pacific: Pessary Market, by End Use, 2019-2032 (USD Million)
    • 7.5.2. Asia Pacific: Pessary Market, by Type, 2019-2032 (USD Million)
    • 7.5.3. Pessary Market - China
      • 7.5.3.1. China: Pessary Market, by End Use, 2019-2032 (USD Million)
      • 7.5.3.2. China: Pessary Market, by Type, 2019-2032 (USD Million)
    • 7.5.4. Pessary Market - India
      • 7.5.4.1. India: Pessary Market, by End Use, 2019-2032 (USD Million)
      • 7.5.4.2. India: Pessary Market, by Type, 2019-2032 (USD Million)
    • 7.5.5. Pessary Market - Malaysia
      • 7.5.5.1. Malaysia: Pessary Market, by End Use, 2019-2032 (USD Million)
      • 7.5.5.2. Malaysia: Pessary Market, by Type, 2019-2032 (USD Million)
    • 7.5.6. Pessary Market - Japan
      • 7.5.6.1. Japan: Pessary Market, by End Use, 2019-2032 (USD Million)
      • 7.5.6.2. Japan: Pessary Market, by Type, 2019-2032 (USD Million)
    • 7.5.7. Pessary Market - Indonesia
      • 7.5.7.1. Indonesia: Pessary Market, by End Use, 2019-2032 (USD Million)
      • 7.5.7.2. Indonesia: Pessary Market, by Type, 2019-2032 (USD Million)
    • 7.5.8. Pessary Market - South Korea
      • 7.5.8.1. South Korea: Pessary Market, by End Use, 2019-2032 (USD Million)
      • 7.5.8.2. South Korea: Pessary Market, by Type, 2019-2032 (USD Million)
  • 7.6. Pessary Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Pessary Market, by End Use, 2019-2032 (USD Million)
    • 7.6.2. Middle East & Africa: Pessary Market, by Type, 2019-2032 (USD Million)
    • 7.6.3. Pessary Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Pessary Market, by End Use, 2019-2032 (USD Million)
      • 7.6.3.2. Saudi Arabia: Pessary Market, by Type, 2019-2032 (USD Million)
    • 7.6.4. Pessary Market - UAE
      • 7.6.4.1. UAE: Pessary Market, by End Use, 2019-2032 (USD Million)
      • 7.6.4.2. UAE: Pessary Market, by Type, 2019-2032 (USD Million)
    • 7.6.5. Pessary Market - Israel
      • 7.6.5.1. Israel: Pessary Market, by End Use, 2019-2032 (USD Million)
      • 7.6.5.2. Israel: Pessary Market, by Type, 2019-2032 (USD Million)
    • 7.6.6. Pessary Market - South Africa
      • 7.6.6.1. South Africa: Pessary Market, by End Use, 2019-2032 (USD Million)
      • 7.6.6.2. South Africa: Pessary Market, by Type, 2019-2032 (USD Million)
  • 7.7. Pessary Market - Latin America
    • 7.7.1. Latin America: Pessary Market, by End Use, 2019-2032 (USD Million)
    • 7.7.2. Latin America: Pessary Market, by Type, 2019-2032 (USD Million)
    • 7.7.3. Pessary Market - Mexico
      • 7.7.3.1. Mexico: Pessary Market, by End Use, 2019-2032 (USD Million)
      • 7.7.3.2. Mexico: Pessary Market, by Type, 2019-2032 (USD Million)
    • 7.7.4. Pessary Market - Brazil
      • 7.7.4.1. Brazil: Pessary Market, by End Use, 2019-2032 (USD Million)
      • 7.7.4.2. Brazil: Pessary Market, by Type, 2019-2032 (USD Million)
    • 7.7.5. Pessary Market - Argentina
      • 7.7.5.1. Argentina: Pessary Market, by End Use, 2019-2032 (USD Million)
      • 7.7.5.2. Argentina: Pessary Market, by Type, 2019-2032 (USD Million)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Bioteque America
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Bliss GVS Pharma
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. CooperSurgical Inc
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Dr. Arabin GmbH & Co. KG
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Integra LifeSciences
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. MedGyn
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Panpac Medical Corporation
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Personal Medical Corporation
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Wallach Surgical Devices
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦